UncategorizedBiomodal launches certified service network for Duet multiomics sequencing – Longevity.Technology Empower Meds / October 10, 2025
UncategorizedSerotonin expands Missouri presence with new Joplin center – Longevity.Technology Empower Meds / October 10, 2025
UncategorizedAnnovis reveals biomarker data from Alzheimer’s drug trial – Longevity.Technology Empower Meds / October 10, 2025
UncategorizedWisp and Vesalius partner to launch women’s peptide therapeutics – Longevity.Technology Empower Meds / October 10, 2025
UncategorizedAlterity reports encouraging ATH434 Phase 2 data at Parkinson’s congress – Longevity.Technology Empower Meds / October 10, 2025
UncategorizedTruDiagnostic wins NIH SBIR funding to develop epigenetic diagnostic model – Longevity.Technology Empower Meds / October 10, 2025
UncategorizedKneu lands funding to monitor neurodegeneration via smartphone Empower Meds / October 9, 2025
UncategorizedSei and WaiveDx partner to build a blockchain healthspan economy Empower Meds / October 9, 2025
UncategorizedCND Life Sciences receives FDA breakthrough designation for Syn-One Test – Longevity.Technology Empower Meds / October 9, 2025
